Skip to main content

Contact Dermatitis News

Related terms: Allergic Dermatitis, Dermatitis, Allergic, Dermatitis, Contact

Novel Treatments Recommended for Management of Atopic Dermatitis in Adults

FRIDAY, July 25, 2025 – In an update to the guidelines for managing atopic dermatitis in adults, four new treatment recommendations are presented. The focused update was published online July 16 in...

FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo

THURSDAY, July 24, 2025 — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). CHE is common condition ma...

High Dietary Inflammatory Index Tied to Increased Prevalence of Eczema

TUESDAY, July 15, 2025 – A high dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased prevalence of atopic dermatitis (AD), according to...

Atopic Dermatitis May Be Linked to Increased Risk for CKD

TUESDAY, July 15, 2025 – Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, according to a study published online July 10 in the...

Prevalence, Incidence of Eczema Increase With Severity of Alopecia Areata

MONDAY, July 14, 2025 – Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), according to a study published online June 26 in...

Early Dog Exposure May Modify Genetic Effect on Atopic Eczema Risk

MONDAY, June 9, 2025 – Early-life dog exposure may modify the genetic effect of the single nucleotide variant rs10214237 on atopic eczema (AE) via IL7R, according to a study published online June 4...

Fido Might Protect Your Baby Against Eczema

THURSDAY, June 5, 2025 — Having a family dog might decrease a baby’s risk of developing eczema later in childhood, a new evidence review says. Specifically, exposure to canines appears to influence a ...

AAP Updates Guidelines for Pediatric Atopic Dermatitis Management

MONDAY, May 19, 2025 – In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis ...

Global Burden of Atopic Dermatitis in Older Adults Is Considerable

WEDNESDAY, May 7, 2025 – The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050, according to a study published online April 1 in...

Early-Onset Pediatric Atopic Dermatitis Tied to Higher Risk for Uveitis

WEDNESDAY, April 23, 2025 – Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published online April 3 in JAMA Ophthalmology. Yung-Yu ...

Roflumilast Cream 0.05 Percent Safe, Effective in Young Children With Eczema

FRIDAY, March 14, 2025 – Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in P...

AAD: Maintenance of Low Eczema Activity Seen After About 80 Days Off Tapinarof

FRIDAY, March 14, 2025 – Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease activity after about 80 days off treatment,...

Early Childhood Stressful Life Events Linked to Increased Eczema Activity

WEDNESDAY, Feb. 5, 2025 – For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased risk for disease activity, according to a study published...

Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis

WEDNESDAY, Jan. 22, 2025 – Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema, desquamation, dryness, and oozing affecting the face, neck,...

FDA Expands Approval of Vtama to Include Atopic Dermatitis

THURSDAY, Dec. 19, 2024 – The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication – the topical treatment of atopic dermatitis in adult and...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatitis

Related drug support groups

prednisone, methylprednisolone, clobetasol, Dupixent, fluocinonide, dexamethasone, desonide, halobetasol, dupilumab